CNIC to host CardioTox 25, the leading international congress on cardiovascular health in cancer patients

From November 4 to 6, the Centro Nacional de Investigaciones Cardiovasculares (CNIC) will host CardioTox 25, the leading international congress dedicated to cardiovascular health in cancer patients.

As in previous editions, the event will bring together professionals from multiple disciplines—including oncology, hematology, cardiology, primary care, nursing, and other health fields—with a shared goal: optimizing cardiovascular care throughout the cancer journey. The congress will be chaired by cardiologist Dr. Teresa López-Fernández, who also participates in CNIC-coordinated research projects.

The program features a distinguished panel of national and international experts who will address the latest advances and practical approaches in cardio-oncology and onco-hematology.

Dr Borja Ibáñez, CNIC Scientific Director, cardiologist at Fundación Jiménez Díaz, and senior member of the Spanish cardiovascular research network CIBERCV , serves on the congress scientific committee. Dr. Ibáñez leads several cardio-oncology projects that will be discussed during the meeting, including RESILIENCE (Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines), funded by the European Commission, and LURK (Anthracycline Legacy in Bone Marrow and Long-Term Cardiovascular Risks in Cancer Survivors), supported by the Fundación "La Caixa".

More information: https://tacticsmd.net/congreso/cardiotox